Author: Samantha Crist

< Back to Thought Leadership

HRSA Reissues 340B Rebate Model Pilot

After over six months of legal uncertainty, HRSA has issued a revised rebate model pilot impacting Medicare Fair Price drugs. On July 31st, the Health Resources & Service Administration (HRSA) […]

Read More

Annual Wellness Visits: Understanding their Value

Performing Annual Wellness Visits (AWVs) provides a unique value that benefits your healthcare organization, providers and your patients. AWVs align with population health management, and can identify any needs for […]

Read More

What are Annual Wellness Visits?

Beginning in 2011, Medicare began covering the Annual Wellness Visit (AWV) as a yearly appointment with a primary care provider (PCP) to create or update a personalized prevention plan at […]

Read More

Unrelated Business Income and Alternative Investment Risks for Healthcare Organizations

Unrelated business income (UBI) remains one of the most fact-intensive areas of federal tax compliance for all exempt-organizations, particularly healthcare organizations. As health systems diversify revenue, expand ancillary services, and […]

Learn More

Public Dealership Group Performance: Mid-Year 2026 PVR Trends and Outlook

By Jonah Gjertson, Senior Consultant at Blue & Co. Starting Point The first half of 2026 has remained relatively stable among the public dealership groups, with new profit per vehicle […]

Learn More
The U.S. Capitol Building in Washington D.C., representing the source of new Medicare legislation.

Newly Proposed Medicare Rules Create Significant 340B Impacts

This summer, the Centers for Medicare and Medicaid Services (CMS) proposed two new rules that, if finalized, will have significant financial and operational impacts on 340B covered entities. In early […]

Learn More